{"id":"NCT02746991","sponsor":"EyePoint Pharmaceuticals, Inc.","briefTitle":"Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis","officialTitle":"A Multi-center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-02","primaryCompletion":"2019-10-04","completion":"2019-10-04","firstPosted":"2016-04-21","resultsPosted":"2020-07-07","lastUpdate":"2020-07-21"},"enrollment":153,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Posterior Uveitis","Intermediate Uveitis","Panuveitis"],"interventions":[{"type":"DRUG","name":"Sham Injection","otherNames":["Placebo"]},{"type":"DRUG","name":"FAI Insert","otherNames":["Fluocinolone Acetonide"]}],"arms":[{"label":"Sham Injection","type":"SHAM_COMPARATOR"},{"label":"FAI Insert","type":"EXPERIMENTAL"}],"summary":"Phase 3, multi-center, randomized, masked, controlled study to evaluate the safety and efficacy of an injectable fluocinolone acetonide intravitreal (FAI) insert for the management of subjects with chronic non-infectious uveitis affecting the posterior segment of the eye. Patients will be randomized to receive either a sham injection or the FAI insert and will be observed for three years following treatment.","primaryOutcome":{"measure":"Number of Participants With Recurrence of Uveitis in Study Eye Within 6 Months","timeFrame":"6 Months","effectByArm":[{"arm":"Sham Injection","deltaMin":28,"sd":null},{"arm":"FAI Insert","deltaMin":22,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":30},"locations":{"siteCount":15,"countries":["India"]},"refs":{"pmids":["38027419"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":52},"commonTop":["Uveitis","Cataract subcapsular","Intraocular pressure increased","Cataract","Vitreous haze"]}}